Robert Motzer MD

Robert Motzer, MD, is professor of medicine at Weill Medical College of Cornell University in New York, New York. He is an attending physician in the Division of Solid Tumor Oncology, Department of Medicine, at Memorial Sloan-Kettering Cancer Center in New York.

After receiving his medical degree from the University of Michigan Medical School in Ann Arbor, Michigan, Dr Motzer completed an internship and residency in internal medicine at North Shore University Hospital in Manhasset, New York, and Memorial Sloan-Kettering Cancer Center. Subsequently, he completed a fellowship in medical oncology/hematology at Memorial Sloan-Kettering Cancer Center, as well as a fellowship in medicine at Cornell University Medical Center.

Dr Motzer’s research interests are focused on treatments for genitourinary malignancies. He was the lead investigator on more than 50 clinical trials of treatments for patients with kidney cancer and testicular cancer. His research helped identify sunitinib and temsirolimus as effective first-line therapies for renal cell carcinoma. Dr Motzer also helped develop a system to predict treatment outcomes in patients with advanced kidney cancer.

The author of numerous book chapters and more than 170 articles in such prestigious journals as The New England Journal of Medicine, Journal of the American Medical Association, and Journal of Clinical Oncology, Dr Motzer serves as a reviewer for the Journal of Clinical Oncology, Annals of Oncology, Cancer, and The New England Journal of Medicine, among others. Dr Motzer has served as chairperson of the Genitourinary Tumors Subcommittee of the American Society of Clinical Oncology. In addition, Dr Motzer is chairman of the National Comprehensive Cancer Network Kidney Cancer and Testicular Cancer Guidelines Panels.

Certified by the American Board of Internal Medicine, with a subspecialty in medical oncology, Dr Motzer is also a fellow of the American College of Physicians. He is a member of the American Association for Cancer Research, American Society of Clinical Oncology, and the American Urological Association. Dr Motzer was honored with a Mid-Career Development Award from the National Institutes of Health to study clinical trials and mentoring in oncology research.